Latest news
AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030 - StocktwitsStocktwits · Mon, 10 Aug 2026 23:25:00 GMTEARNINGS_CALL_TRANSCRIPT_TITLE_FORMATTED - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:37:59 GMTInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $9,541,298.04 in Stock - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:41 GMTAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 4,660 Shares - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:40 GMTAxsome CEO Herriot Tabuteau disposes of USD 10.54 million in common shares - BitgetBitget · Fri, 07 Aug 2026 15:00:38 GMT